The Double Effect: In Theory and in Practice

Chapter

Abstract

It is not always possible to perform clinical interventions that benefit a patient without also triggering some degree of harm. The double effect (DE) is both a moral and pragmatic principle to determine whether the good outcome resulting from an action outweighs any detrimental secondary effects. The principle’s underpinnings are lodged in medieval, theological thought, and the continuing clinical significance of DE to a diverse, technological society is the subject of much debate among scientists and philosophers. In the scientific literature, DE is most often invoked to address questions of what is moral and ethical in end-of-life care.

Keywords

Depression Morphine Carbon Monoxide Methotrexate Posit 

Notes

Acknowledgment

Beth Dove of Dove Medical Communications, Salt Lake City, Utah, contributed technical writing and manuscript review. (Note: Please note the spelling of Dove – not Dover – Medical Communications).

References

  1. 1.
    Mangan J. An historical analysis of the principle of double effect. Theol Stud. 1949;10:41–61.Google Scholar
  2. 2.
    Aquinas T. (13th c). Summa Theologica II-II, Q. 64, art. 7, “Of Killing”. In: Baumgarth WP, Richard J, Regan SJ, editors. On law, morality, and politics. Indianapolis/Cambridge: Hackett Publishing Co; 1988. p. 226–7.Google Scholar
  3. 3.
    Sulmasy DP. Killing and allowing to die: another look. J Law Med Ethics. 1998;26(1):55–64.PubMedCrossRefGoogle Scholar
  4. 4.
    Shaw AB. Two challenges to the double effect doctrine: euthanasia and abortion. J Med Ethics. 2002;28(2):102–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Purdy L. Ending life [book review]. JAMA. 2006;295(7):830–1.CrossRefGoogle Scholar
  6. 6.
    Tauber AI. Patient autonomy and the ethics of responsibility. Cambridge: MIT Press; 2005.Google Scholar
  7. 7.
    Quill TE, Dresser R, Brock DW. The rule of double effect – a critique of its role in end-of-life decision making. N Engl J Med. 1997;337(24):1768–71.PubMedCrossRefGoogle Scholar
  8. 8.
    Carlet J, Thijs LG, Antonelli M, et al. Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med. 2004;30(5):770–84. Epub 2004 Apr 20.PubMedCrossRefGoogle Scholar
  9. 9.
    McGee A. Double effect in the criminal code 1899 (QLD): a critical appraisal. QUT Law Just J. 2004;4(1):46–57.Google Scholar
  10. 10.
    Orentlicher D, Caplan A. The pain relief promotion Act of 1999: a serious threat to palliative care. JAMA. 2000;283(2):255–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Annas GJ. Congress, controlled substances, and physician-assisted suicide – elephants in mouseholes. N Engl J Med. 2006;354(10):1079–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Kapp MB. The U.S. Supreme court decision on assisted suicide and the prescription of pain medication: limit the celebration. J Opioid Manag. 2006;2(2):73–4.PubMedGoogle Scholar
  13. 13.
    Vacco v. Quill, 117 S.Ct. 2293. 1997.Google Scholar
  14. 14.
    Washington v. Glucksberg, 117 S.Ct. 2258. 1997.Google Scholar
  15. 15.
    Quill TE, Meier DE. The big chill – inserting the DEA into end-of-life care. N Engl J Med. 2006;354(1):1–3.PubMedCrossRefGoogle Scholar
  16. 16.
    Canick SM. Constitutional aspects of physician-assisted suicide after Lee v. Oregon. Am J Law Med. 1997;23(1):69–96.PubMedGoogle Scholar
  17. 17.
    Reality check on the pain relief promotion act. Secretariat for Pro-Life Activities, United States Conference of Catholic Bishops, 3211 4th Street, N.E., Washington, DC 20017–1194 (202) 541–3070. http://www.nccbuscc.org/prolife/issues/euthanas/reality2.htm. Accessed 17 Aug 2006.
  18. 18.
    Sykes N, Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol. 2003;4(5):312–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Fohr SA. The double effect of pain medication: separating myth from reality. J Palliat Med. 1998;1(4):315–28.PubMedCrossRefGoogle Scholar
  20. 20.
    The use of opioids for the treatment of chronic pain: a consensus statement from American Academy of Pain Medicine and American Pain Society. Approved by the AAPM Board of Directors on 29 June 1996. Approved by the APS Executive Committee on 20 Aug 1996. http://www.ampainsoc.org/advocacy/opioids.htm. Accessed 19 July 2005. Under review.
  21. 21.
    Farney RJ, Walker JM, Cloward TV, Rhondeau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest. 2003;123(2):632–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Wang D, Teichtahl H, Drummer O, Goodman C, Cherry G, Cunnington D, Kronborg I. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128(3):1348–56.PubMedCrossRefGoogle Scholar
  23. 23.
    Webster LR, Grant BJB, Choi Y. Sleep apnea associated with methadone and benzodiazepine therapy [abstract]. Poster presented at the 22nd annual meeting of the American Academy of Pain Medicine (AAPM), San Diego, 2006.Google Scholar
  24. 24.
    White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94(7):961–72.PubMedCrossRefGoogle Scholar
  25. 25.
    Santiago TV, Pugliese AC, Edelman NH. Control of breathing during methadone addiction. Am J Med. 1977;62(3):347–54.PubMedCrossRefGoogle Scholar
  26. 26.
    Schwartz JK. The rule of double effect and its role in facilitating good end-of-life palliative care: a help or a hindrance? J Hosp Palliat Nurs. 2004;6(2):125–33.CrossRefGoogle Scholar
  27. 27.
    Snelling PC. Consequences count: against absolutism at the end of life. J Adv Nurs. 2004;46(4):350–7.PubMedCrossRefGoogle Scholar
  28. 28.
    McIntyre A. Doctrine of double effect. In: Edward NZ, editors. The stanford encyclopedia of philosophy. Summer 2006 ed. 2006. http://plato.stanford.edu/archives/sum2006/entries/double-effect/. Accessed August 20, 2012.
  29. 29.
    Patterson JR, Hodges MO. The rule of double effect [letter]. N Engl J Med. 1998;338(19):1389.PubMedCrossRefGoogle Scholar
  30. 30.
    Cahana A. Is optimal pain relief always optimal? Bioethical considerations of interventional pain management at the end of life. Am Pain Soc Bull. 2002;12(3):1–4.Google Scholar
  31. 31.
    Webster LR. Methadone-related deaths. J Opioid Manag. 2005;1(4):211–7.PubMedGoogle Scholar

Copyright information

© American Academy of Pain Medicine 2013

Authors and Affiliations

  1. 1.Clinical ResearchSalt Lake CityUSA

Personalised recommendations